GMP grade lipopolysaccharides (LPS) vials for manufacturing cancer vaccines in clinical trials

Ended Purchase Order Awarded Last action

Contract number
75N91022P00921
Awardee
Awarding agency
Obligated
$150,000

Award facts

Contract value 100% obligated
$150,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Campbell, CA 95008, USA

Award details come from SAM.gov/FPDS.

About this award

This is a $150,000.00 firm fixed-price purchase order contract awarded by the National Cancer Institute, which is part of the National Institutes of Health under the U.S. Department of Health and Human Services. The contract is for the supply of Good Manufacturing Practice (GMP) grade lipopolysaccharides (LPS) vials to be used in the manufacturing of cancer vaccines for clinical trials. The contract was awarded to List Biological Laboratories, Inc., a for-profit manufacturer of goods, with a place of performance in Campbell, California. The contract does not have a set-aside designation and is scheduled for completion by November 15, 2022.

Quick answers

Who was awarded contract 75N91022P00921?

75N91022P00921 was awarded to List Biological Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2022.

How much is contract 75N91022P00921 worth?

The government has obligated $150,000 on 75N91022P00921.

Was contract 75N91022P00921 competed?

The extent of competition for 75N91022P00921 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award